Trends & Forecasts

Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

Why the CVS-Aetna merger could be a transformative event for the pharmaceutical industry.

EFPIA figures give a snapshot of drug development and innovation in Europe. Check out our infographic for some of the key stats.

No-deal Brexit poses unique challenges for the development and advanced therapy sectors, not least tight timelines and a limited ability to stockpile.

Gene therapy deals, clinical trials transparency and sartan medicine reviews… what’s new for pharma in business?

With the US back to divided government, the US pharma industry could be the number one target for politicians.

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?